A Phase 2b, Randomized, Placebo-Controlled, Observer-Blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Respiratory Syncytial Virus (RSV) Vaccine In Pregnant Women 18 Through 49 Years Of Age And Their Infants

Project: Research

Project Details

Effective start/end date11/02/2010/02/25


  • clinical trial
  • treatment safety
  • treatment efficacy
  • vaccine safety
  • phase 2 study